Ulrich Laufs

University Hospital Leipzig — Germany

Medicine · Health Sciences

105h-index62.9kcitations898works7.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(285), Diabetes, Cardiovascular Risks, and Lipoproteins(76), Cancer, Lipids, and Metabolism(68), Health Systems, Economic Evaluations, Quality of Life(63), Cardiovascular Function and Risk Factors(62)

Publications883 total

Risikofaktor-Management bei polyvaskulärer Atherosklerose
DMW - Deutsche Medizinische Wochenschrift·2025
Treatment pathways of lipid-lowering therapies in Germany 2016–2022
Clinical Research in Cardiology·2025· 3 citedOpen Access
Design and rationale of the VICTORION-Difference study: A phase 4 randomized, double-blind, placebo-controlled clinical trial to assess inclisiran’s early efficacy, safety, tolerability, as well as its impact on quality of life in individuals with hypercholesterolemia
American Heart Journal·2025· 1 citedOpen Access
Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia
Heart·2025· 2 citedOpen Access
Erratum zu: Stellungnahme zur kritischen Bewertung der Nationalen VersorgungsLeitlinie zur chronischen koronaren Herzerkrankung
Die Kardiologie·2025· 1 citedOpen Access
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
New England Journal of Medicine·2025· 58 citedOpen Access
Effects of immunosuppressive therapy on the clinical outcomes in patients with cardiac sarcoidosis
EP Europace·2025Open Access
† Safety and efficacy of obicetrapib in patients with heterozygous familial hypercholesterolemia
Journal of clinical lipidology·2025· 1 cited
Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS study
Acta cardiologica. Supplementum·2025· 2 citedOpen Access
Time for a New Perspective on Polypharmacy in Heart Failure
European Journal of Heart Failure·2025Open Access
Stellungnahme zur kritischen Bewertung der Nationalen VersorgungsLeitlinie zur chronischen koronaren Herzerkrankung
Die Kardiologie·2025· 2 cited
Correspondence
Deutsches Ärzteblatt international·2025Open Access
Cholesterol in women: consideration of lifetime risk
European Journal of Preventive Cardiology·2025· 1 citedOpen Access
Treatment strategies and LDL cholesterol target attainment in patients with statin intolerance: Insights from the multicentre statin intolerance registry
American Journal of Preventive Cardiology·2025· 5 citedOpen Access
Teilstationäre Versorgung in universitären Kliniken für Kardiologie
Die Kardiologie·2025· 1 cited
Repetition‐dependent acute cardiopulmonary responses during intensity‐matched squats in males
Experimental Physiology·2025· 3 citedOpen Access
Positionspapier zum Post-COVID-Syndrom
Die Kardiologie·2025Open Access
Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association study
European Journal of Internal Medicine·2025· 5 citedOpen Access
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
European Heart Journal·2025· 13 citedOpen Access
Excessive Supraventricular Ectopic Activity in Patients With Acute Ischemic Stroke Is Associated With Atrial Fibrillation Detection Within 24 Months After Stroke: A Predefined Analysis of the MonDAFIS Study
Journal of the American Heart Association·2025· 4 citedOpen Access
page 1 of 45Next →

Frequent Co-authors

Michael Böhm(23), Georg Nickenig(13), Alberico L. Catapano(12), Kausik K. Ray(11), James K. Liao(10), Matthias Endres(10), Henry N. Ginsberg(9), Éric Bruckert(7), Frederick J. Raal(7), Børge G. Nordestgaard(7), M. John Chapman(7), Winfried März(7), Brian A. Ference(6), Olov Wiklund(6), Robert A. Hegele(6), Erik S.G. Stroes(6), Chris J. Packard(5), Ronald M. Krauss(5), Stephen J. Nicholls(5), Lâle Tokgözoğlu(5)